| Dr Juan Ed Torres-reveron, MD/ PHD | |
|
5519 Doctors Dr, Edinburg, TX 78539-5563 | |
| (956) 362-8500 | |
| (956) 362-8505 |
| Full Name | Dr Juan Ed Torres-reveron |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 17 Years |
| Location | 5519 Doctors Dr, Edinburg, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689858706 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Henry Ford Allegiance Health | Jackson, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| W.a. Foote Memorial Hospital, Inc. | 0244136067 | 435 |
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Researchers in France have identified a molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions.
A clinic in a low-income Milwaukee neighborhood has filled a need for 23 years, but people running it worry that it may not be helped by any changes to the health care system. The New York Times reports on the Milwaukee Immediate Care Center, a small nonprofit clinic, "which keeps hours at night and on weekends, [and] is the only full-time operation in the neighborhood that provides urgent care, luring patients with a sign that reads, 'When You Need a Doctor Today.'"
Women who survive a stroke are less likely than men to get crucial tests of their heart and neck arteries that can help improve their treatment and reduce their risk of a second stroke, a new University of Michigan study finds.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
› Verified 6 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
Researchers in France have identified a molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions.
A clinic in a low-income Milwaukee neighborhood has filled a need for 23 years, but people running it worry that it may not be helped by any changes to the health care system. The New York Times reports on the Milwaukee Immediate Care Center, a small nonprofit clinic, "which keeps hours at night and on weekends, [and] is the only full-time operation in the neighborhood that provides urgent care, luring patients with a sign that reads, 'When You Need a Doctor Today.'"
Women who survive a stroke are less likely than men to get crucial tests of their heart and neck arteries that can help improve their treatment and reduce their risk of a second stroke, a new University of Michigan study finds.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Juan Ed Torres-reveron, MD/ PHD 10843 Rock Rose Pl, Plain City, OH 43064-9806 Ph: (203) 506-3384 | Dr Juan Ed Torres-reveron, MD/ PHD 5519 Doctors Dr, Edinburg, TX 78539-5563 Ph: (956) 362-8500 |
News Archive
Researchers in France have identified a molecular motor that controls the release of inflammatory factors that cause severe and fatal allergic reactions.
A clinic in a low-income Milwaukee neighborhood has filled a need for 23 years, but people running it worry that it may not be helped by any changes to the health care system. The New York Times reports on the Milwaukee Immediate Care Center, a small nonprofit clinic, "which keeps hours at night and on weekends, [and] is the only full-time operation in the neighborhood that provides urgent care, luring patients with a sign that reads, 'When You Need a Doctor Today.'"
Women who survive a stroke are less likely than men to get crucial tests of their heart and neck arteries that can help improve their treatment and reduce their risk of a second stroke, a new University of Michigan study finds.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
› Verified 6 days ago
Dr. Achal Patel, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 | |
Dr. Jacinto I Manon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 | |
Michael Burke, MD,FACS,FAAP Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2821 Michaelangelo Dr, Ste 200, Edinburg, TX 78539 Phone: 956-362-8215 Fax: 956-362-8219 | |
Patricia Fernandez, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2821 Michaelangelo Dr Ste 304, Edinburg, TX 78539 Phone: 956-362-8501 Fax: 956-362-8505 | |
Dr. Jaime Gasco-tamarit, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4302 S Sugar Rd Ste 100, Edinburg, TX 78539 Phone: 956-292-0570 Fax: 956-292-0102 | |
Dr. Inad Badreddin Atassi, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 |